Literature DB >> 26747711

Histopathologic Evaluation of Vascular Findings in the Cochlea in Patients With Presbycusis.

Natsuko Kurata1, Patricia A Schachern1, Michael M Paparella2, Sebahattin Cureoglu1.   

Abstract

IMPORTANCE: Age-related changes in cochlear vessel wall thickness in human temporal bones have not been described previously.
OBJECTIVES: To compare thickness of the spiral modiolar artery and strial capillaries and to investigate strial atrophy and vessel loss in temporal bones with and without presbycusis. DESIGN, SETTING, AND PARTICIPANTS: This retrospective case-control study examined the autopsy reports of 1024 patients in the temporal bone collection at the University of Minnesota. Inclusion criteria consisted of being 60 years or older with sensorineural hearing loss and progression of hearing loss with age (presbycusis group). Age-matched controls had no record of hearing loss. All patients underwent pure-tone audiometry. Exclusion criteria included a history of otologic disease, ototoxic drug use, head or acoustic trauma, or systemic disease. Data were collected from October 1, 2013, to October 1, 2014. MAIN OUTCOMES AND MEASURES: Vessel wall thickness in the modiolar artery and strial vessels, the strial area, and number of strial vessels were measured under light microscopy.
RESULTS: Among the 1024 autopsy reports examined, 11 patients (19 temporal bones) with presbycusis (7 men and 4 women; age range, 67-88 years; mean [SD] age, 78 [7] years]) and 15 controls (24 temporal bones) (7 men and 8 women; age range, 67-94 years; mean [SD] age, 79 [8] years) met the inclusion criteria. Compared with the control group, the presbycusis group had significantly increased mean (SD) thickness of vessel walls in the modiolar arteries (6.73 [2.39] vs 5.55 [0.86] μm; P = .02) and the strial capillaries in the lower basal (1.57 [0.21] vs 1.39 [0.15] μm; P = .005), upper basal (1.62 [0.28] vs 1.40 [0.13] μm; P < .001), lower middle (1.68 [0.22] vs 1.39 [0.20] μm; P < .001), upper middle (1.74 [0.39] vs 1.40 [0.19] μm; P = .01), and apical (1.70 [0.36] vs 1.47 [0.21] μm; P = .04) turns of the cochlea. Compared with the control group, the presbycusis group had significant loss of strial area in the lower basal (6614 [1559] vs 8790 [1893] μm2; P = .002), upper basal (6387 [2211] vs 9105 [2700] μm2; P < .001), lower middle (5140 [1471] vs 7269 [2181] μm2; P = .003), upper middle, (5583 [1742] vs 7206 [2258] μm2; P = .02), and apical (4286 [1604] vs 6535 [2454] μm2; P < .001) turns of the cochlea; in the vessel area in the lower basal turn (74.65 [127.74] vs 124.92 [89.04] μm2; P = .01); and in the number of vessels in the lower basal (1.00 [0.78] vs 1.94 [0.93]; P = .008) and lower middle (1.00 [0.78] vs 1.94 [0.93]; P = .04) turns of the cochlea. CONCLUSIONS AND RELEVANCE: The histopathologic findings of increased thickness of the vascular walls of the modiolar arteries and stria vascularis, increased strial atrophy, and decreased number of strial vessels may have led to decreased cochlear microcirculation. Deficiency in the circulation and perfusion of the cochlea may be a factor in presbycusis.

Entities:  

Mesh:

Year:  2016        PMID: 26747711     DOI: 10.1001/jamaoto.2015.3163

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  11 in total

Review 1.  Systemic Lupus Erythematosus and hearing disorders: Literature review and meta-analysis of clinical and temporal bone findings.

Authors:  A Di Stadio; Massimo Ralli
Journal:  J Int Med Res       Date:  2017-02-20       Impact factor: 1.671

2.  Associations of Retinal Vessel Caliber With Hearing Status in Childhood and Midlife: A Cross-Generational Population-Based Study.

Authors:  Jing Wang; Mengjiao Liu; Valerie Sung; Kate Lycett; Anneke Grobler; David Burgner; Tien Yin Wong; Melissa Wake
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-04-01       Impact factor: 6.223

3.  Relationship of stroke risk and hearing loss in African Americans: The Jackson Heart Study.

Authors:  Jonathan E Sorrel; Charles E Bishop; Christopher Spankovich; Dan Su; Karen Valle; Samantha Seals; John M Schweinfurth
Journal:  Laryngoscope       Date:  2017-10-09       Impact factor: 3.325

4.  Characteristics of the Cochlear Symptoms and Functions in Meniere's Disease.

Authors:  Yi Zhang; Bo Liu; Rui Wang; Ruo Jia; Xin Gu
Journal:  Chin Med J (Engl)       Date:  2016-10-20       Impact factor: 2.628

Review 5.  Pathology and mechanisms of cochlear aging.

Authors:  Elizabeth M Keithley
Journal:  J Neurosci Res       Date:  2019-05-07       Impact factor: 4.164

Review 6.  Cochlear Inflammaging in Relation to Ion Channels and Mitochondrial Functions.

Authors:  Parveen Bazard; Jennifer Pineros; Robert D Frisina; Mark A Bauer; Alejandro A Acosta; Lauren R Paganella; Dominika Borakiewicz; Mark Thivierge; Freyda L Mannering; Xiaoxia Zhu; Bo Ding
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

Review 7.  Hearing Function, Degeneration, and Disease: Spotlight on the Stria Vascularis.

Authors:  Matsya R Thulasiram; Jacqueline M Ogier; Alain Dabdoub
Journal:  Front Cell Dev Biol       Date:  2022-03-04

8.  Estimation of Volume of Stria Vascularis and the Length of Its Capillaries in the Human Cochlea.

Authors:  Sree Vani Poorna Pillutla; Charanjeet Kaur; Tara Sankar Roy; Tony George Jacob
Journal:  J Microsc Ultrastruct       Date:  2019 Jul-Sep

9.  Protective Effects of Adiponectin against Cobalt Chloride-Induced Apoptosis of Smooth Muscle Cells via cAMP/PKA Pathway.

Authors:  Jingjie Xiao; Yingying Zhang; Wei Zhang; Liang Zhang; Li Li; Junqiang Si; Xinzhi Li; Ketao Ma
Journal:  Biomed Res Int       Date:  2020-10-10       Impact factor: 3.411

10.  Associations of sensory impairment and cognitive function in middle-aged and older Chinese population: The China Health and Retirement Longitudinal Study.

Authors:  Xiaohuan Zhao; Yifan Zhou; Kunchen Wei; Xinyue Bai; Jingfa Zhang; Minwen Zhou; Xiaodong Sun
Journal:  J Glob Health       Date:  2021-12-18       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.